NICE has recommended obecabtagene autoleucel for adults with relapsed or refractory B-cell ALL, offering a potentially more effective option to existing therapies.
Medscape News UK
Source link : https://www.medscape.com/viewarticle/nice-recommends-new-car-t-therapy-adult-all-2025a1000wzf?src=rss
Author :
Publish date : 2025-11-25 17:42:00
Copyright for syndicated content belongs to the linked Source.
